Search for: "CIPLA"
Results 141 - 160
of 202
Sort by Relevance
|
Sort by Date
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
16 Jan 2009, 7:00 am
(Spicy IP) Global credit crisis leads to boom times for legal process outsourcing businesses specialising in IP (Spicy IP) Israel Israeli bakery Matzot Aviv files trade mark infringement suit against rival Patisserie Aviv and US importer Bagel Bites (The IP Factor) Israel Patent Office relaxes conditions for modified examination (The IP Factor) Italy Italian Supreme Court recognises ‘post sale confusion’ in criminal proceedings concerning sales of… [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
17 Dec 2008, 9:57 pm
In past Patent Circle exclusively brought in notice couple of patents issued to Cipla for new forms of known drugs, namely, esomeprazole and alendronate and accused Cipla of practicing double standards on patenting so-called trivial improvements. [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic medicine… [read post]
11 Dec 2008, 3:58 pm
In another development, the Mumbai High Court restrained Cipla from using the trademark "Valcept" for its generic version of Valycte. [read post]
3 Dec 2008, 9:41 pm
There is considerable likelihood that the decision may impact ongoing case in the Mumbai High Court between Roche and Cipla, possibly going in favor of Cipla. [read post]
14 Oct 2008, 4:52 pm
In January, Cipla launched the generic copy of Tarceva and was sued by Roche for infringement of patent in the Delhi High Court. [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense to Walker… [read post]
30 Sep 2008, 3:00 am
In parallel, Roche is also facing post-grant oppositions from Ranbaxy, Cipla and the Delhi Network of Positive People in the Chennai Patent Office. [read post]
27 Sep 2008, 12:08 am
(Biotech Blog) United States: Patent for generating oxygen in a process that mimics photosynthesis (Competitive info) Products Adderall (Dextroamphetamine/Racemic DL-ampthetamine) - US: Judge denies Sandoz’ bid for summary judgment of non infringement in patent dispute with Shir eover Adderall (Law360) Carbatrol (Carbamazepine) - US: Judge refuses to grant summary judgment to Corepharma in patent dispute with Shire Laboratories over generic Carbatrol (Law360) Clarinex… [read post]
25 Sep 2008, 10:47 am
This is the second instance of Cipla mocking Indian patent after it deliberately launched generic copy of Roche patented anti-cancer drug Erlotinib. [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 Aug 2008, 2:43 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
24 Jul 2008, 2:48 am
The judge gave preliminary approval last week for the company to pay $13.5 million to settle the suit.Indian Drugmaker Openly Plans for Release of Copycats: Cipla Ltd, India's second largest drug maker by sales, may launch copycat versions of 20 patented drugs of leading global drug makers, after securing similar-sounding trademarks for its copy brands.Cipla "may launch these generic brands in the market as and when the opportunity arises", claimed a company executive, who… [read post]
18 Jul 2008, 8:34 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
14 Jul 2008, 3:12 pm
It seems to be like Erlotinib (Tarceva), Cipla will again go ahead disrespecting patents for other anti-cancer drugs. [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
